AstraZeneca: pharma needs to lead by example on sustainabilityPaul Tunnah sat down with AstraZeneca’s vice president of sustainability strategy and engagement Jim Massey to discuss how Share XAstraZeneca: pharma needs to lead by example on sustainabilityhttps://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-pharma-needs-to-lead-by-example-on-sustainability/
Homeschooling resources during coronavirus working-from-homeWith schools closed and many pharma and healthcare companies asking employees to work from home during the coronavirus Share XHomeschooling resources during coronavirus working-from-homehttps://pharmaphorum.com/views-analysis-sales-marketing/homeschooling-resources-coronavirus-covid19-working-home/
UK Leaders: Gilead’s Hilary Hutton-Squire on building trust with the NHSAs general manager of Gilead UK and Ireland, Hilary Hutton-Squire has been at the forefront of bringing several Share XUK Leaders: Gilead’s Hilary Hutton-Squire on building trust with the NHShttps://pharmaphorum.com/views-analysis-sales-marketing/uk-leaders-gilead-hilary-hutton-squire-on-building-trust-with-the-nhs/
How pharma can adapt to climate changeClimate change is perhaps the most complex issue facing modern society, affecting every aspect of human life including Share XHow pharma can adapt to climate changehttps://pharmaphorum.com/sales-marketing/how-pharma-can-adapt-to-climate-change/
Coronavirus pharma conference monitor – event impact of COVID-19The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for Share XCoronavirus pharma conference monitor – event impact of COVID-19https://pharmaphorum.com/views-and-analysis/coronavirus-pharma-conference-monitor/
Does pharma’s future lie in China?Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders. Some Share XDoes pharma’s future lie in China?https://pharmaphorum.com/r-d/views-analysis-r-d/does-pharmas-future-lie-in-china/
Customer experience in pharma: Getting the journey rightAs part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, Share XCustomer experience in pharma: Getting the journey righthttps://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/
UK leaders: Takeda’s Jon NealIn the first of a new series where we talk to GMs of UK pharma divisions, managing director Share XUK leaders: Takeda’s Jon Nealhttps://pharmaphorum.com/views-analysis-market-access/uk-leaders-takeda-jon-neal/
Is Tecfidera’s patent win a pyrrhic victory for Biogen?Shares in Biogen jumped last week after the company successfully defended its blockbuster MS drug Tecfidera from a Share XIs Tecfidera’s patent win a pyrrhic victory for Biogen?https://pharmaphorum.com/views-analysis-sales-marketing/tecfideras-patent-pyrrhic-victory-biogen/
